[News from our partners] The partnership will assess particular aspects of the MARS 5x120 Extremity scanner.
This funding supports the commercialization of Terapet’s first product, Qualγscan and the development of new nuclear imaging products.
CERN, CHUV and THERYQ have signed an agreement for the development of a revolutionary FLASH radiotherapy device
A novel proton accelerator for cancer treatment, based on CERN technology, is getting ready to receive its first patients in the United Kingdom